Esperion Presents Results from CLEAR Outcomes Primary Preven

– 30% risk reduction of MACE-4 composite of death from cardiovascular causes, and >25% risk reduction across four key secondary endpoints in primary prevention population, including 27% reduction in all-cause

Related Keywords

United States , Monash , South Australia , Australia , Melbourne , Victoria , American , Tiffany Aldrich , Sheldon Koenig , Joanne Foody , Stephen Nicholls , Alexis Callahan , Monash University , Twitter , Exchange Commission , Journal Of The American Medical Association , American Diabetes Association , American Medical Association , Primary Prevention , Cardiovascular Events , Statin Intolerant Patients , Victorian Heart Hospital , Anne Foody , Chief Medical Officer , Primary Prevention Analysis , Acid Effects , High Sensitivityc Reactive Protein , Prescribing Information , Contact Information , Medication , Cholesterol , Health ,